Board Chair Dr. Craig R. Barrett to retire; CEO James J. Rhyu to become Chair

Stride, Inc.

Dr. Craig R. Barrett will not stand for re-election at 2024 Annual Meeting, retiring as Chair and Board member.
CEO James J. Rhyu will succeed Dr. Barrett as Chair of the Board effective after the Annual Meeting.
Steven B. Fink appointed as lead independent director effective after the Annual Meeting.
Board size reduced from nine to eight directors after Barrett's retirement.

item 5.02 item 7.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Craig R. Barrett

Chair of the Board

LRN · Stride, Inc.

Filed: May 17, 2024, 7:59 PM ET

On May 15, 2024, Dr. Craig R. Barrett notified Stride, Inc. (the “Company”) of his decision not to stand for re-election to the board of directors of the Company (the “Board”) at the 2024 annual meeting of stockholders (“Annual Meeting”) and will retire from the Board and from the role of Chair of the Board, effective at the conclusion of the Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Craig R. Barrett departed as Chair of the Board at Stride, Inc..

Action: retire
Role: Chair of the Board

Exact text from the filing

On May 15, 2024, Dr. Craig R. Barrett notified Stride, Inc. (the “Company”) of his decision not to stand for re-election to the board of directors of the Company (the “Board”) at the 2024 annual meeting of stockholders (“Annual Meeting”) and will retire from the Board and from the role of Chair of the Board, effective at the conclusion of the Annual Meeting.

View on SEC.gov

Stride, Inc. filing history →

Source: SEC EDGAR

accession 0001171843-24-002954

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.